New State-of-the-Art Lone Star Endoscopy Center Open in Southlake, TX
Texas Digestive Disease Consultants (TDDC) is proud to announce the opening of the brand-new ambulatory surgery center, Lone Star Endoscopy in Southlake, TX. The newly constructed 11,000 square foot endoscopy center is the third Lone Star Endoscopy location in the Dallas-Fort Worth metroplex. Lone Star Endoscopy Center, Southlake features 5 endoscopy suites with a modern design and state-of-the-art endoscopic equipment. The new center is conveniently located at 515 South Nolen Drive directly behind the TDDC Southlake clinic. The proximity between the clinic (which includes an infusion center and pathology lab) and the endoscopy center provides added convenience for patients as well as physicians who travel between facilities.
Lone Star Endoscopy Centers have been nationally recognized and are known for achieving high patient satisfaction scores. In a 2017 survey conducted by Press Ganey, Lone Star Endoscopy received a 99% patient satisfaction rating. Patients can expect to receive the same high-quality care in a new and comfortable environment at Lone Star Endoscopy Center, Southlake.
To schedule an appointment, please call (817) 898-8900.
New Endoscopy Center Location:
515 South Nolen Drive
Southlake, TX 76092
Texas Digestive Disease Consultants (TDDC) is the largest gastroenterology group in the United States with over 120 board-certified physicians committed to providing high quality patient care throughout the state of Texas. Founded in 1995, TDDC has grown to over 40 locations throughout Dallas-Fort Worth, Austin, San Marcos, San Antonio, and future locations across Houston. TDDC’s integrated network of clinics, endoscopy centers, pathology lab, infusion centers, COPE Center for Colorectal & Pelvic Health, and Department of Clinical Research allows our gastroenterologists to provide comprehensive care for patients. The Department of Clinical Research & Education is actively involved in several national clinical trials specializing in the latest therapeutic advancements for gastrointestinal and liver disorders.